KTN is pleased to announce an afternoon event to discuss the current state of the art, challenges and potential solutions around analysis of adeno-associated virus and lentiviral vectors.

Join us if you would like to hear about the current state of the art for viral vector analytics, as well as its challenges. In addition, we will cover potential solutions.

The event will include contributions from speakers representing companies, academia, RTOs and others. In addition, there will be an opportunity for solution providers to provide a short two minute video to be shared with attendees in a video gallery. Two of the submissions will be selected by the organising committee for plenary display. The final session will be a panel discussion to revisit the issues raised in the preceding presentations.

Confirmed speakers and panelists

●  Farzin Farzaneh, Chief Scientific Officer, ViroCell Biologics
●  Julia Leach, Senior Scientist – Analytical, CPI
●  Peng Wang, Scientist II, Lonza
●  Yuan Zhao, Principal Scientist / Section Head, NIBSC
●  Mike Baker, Senior Director, FUJIFILM Diosynth Biotechnologies
●  Alan Dickson, Professor of Biotechnology, University of Manchester

After the plenary sessions there will be an opportunity to set up 1:1 video calls with other attendees.

Organising committee:

●  Karen Wilkinson, KTN
●  Marcel Kuiper, KTN
●  Joanne Flannelly, University of Manchester / BioProNET2
●  Alan Dickson, University of Manchester / BioProNET2
●  Rebecca Horlock, FUJIFILM Diosynth Biotechnologies
●  Daniel Petit, FUJIFILM Diosynth Biotechnologies
●  Robert Forbes, University of Central Lancashire / FUJIFILM Diosynth
Biotechnologies
●  Julia Leach, CPI
●  Lee Dunham, Cell and Gene Therapy Catapult

Draft Agenda

  • 14:00 – Welcome and KTN update | Karen Wilkinson  KTN

Session 1: Challenges for viral vector analytics. Chair: Mike Baker (FUJIFILM Diosynth Biotechnologies)

  • 14:10 – “lentiviral vector analysis; state of the art and challenges”  Farzin Farzaneh | Chief Scientific Officer, ViroCell, Professor of Molecular Medicine, King’s College London
  • 14:25 – “AAV viral vector analysis; state of the art and challenges”  Peng Wang | Scientist II, Lonza
  • 14:40 – “Current and future regulatory expectations for AAV and lentiviral vector analytics”  Yuan Zhao  NIBSC
  • 14:55 – Q&A

Session 2: Exploration of novel tools and solutions. Chair: Julia Leach, CPI

  • 15:15 – Two selected videos from analytics solution providers (SME/academia) | TBC
  • 15:20 – “Future direction analytical capabilities” | TBC
  • 15:35 – Q&A
  • 15:45 – Break, novel solution videos

Session 3: Round table discussion led by Prof Alan Dickson (UoM)

With participation from Farzin Farzaneh (ViroCell/KCL), NIBSC (Yuan Chao), CPI (Julia Leach), Mike Baker (FDB), solution provider (TBC)

  • 16:00
    1. Key challenges
    2. Learnings from other biopharmaceuticals
    3. Novel technologies
    4. Future regulatory expectations
    5. Next steps
  • 16:45 – 1:1 video networking, novel solution videos

Register